- Home
- TOL vs PCVX Comparison
TOL vs PCVX Comparison
Compare TOL & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOL
- PCVX
- Stock Information
- Founded
- TOL 1967
- PCVX 2013
- Country
- TOL United States
- PCVX United States
- Employees
- TOL N/A
- PCVX N/A
- Industry
- TOL Homebuilding
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- TOL Consumer Discretionary
- PCVX Health Care
- Exchange
- TOL Nasdaq
- PCVX Nasdaq
- Market Cap
- TOL 14.8B
- PCVX 13.2B
- IPO Year
- TOL N/A
- PCVX 2020
- Fundamental
- Price
- TOL $135.13
- PCVX $85.30
- Analyst Decision
- TOL Buy
- PCVX Strong Buy
- Analyst Count
- TOL 15
- PCVX 9
- Target Price
- TOL $153.67
- PCVX $149.38
- AVG Volume (30 Days)
- TOL 1.5M
- PCVX 1.2M
- Earning Date
- TOL 02-18-2025
- PCVX 02-25-2025
- Dividend Yield
- TOL 0.68%
- PCVX N/A
- EPS Growth
- TOL 21.44
- PCVX N/A
- EPS
- TOL 15.01
- PCVX N/A
- Revenue
- TOL $10,846,740,000.00
- PCVX N/A
- Revenue This Year
- TOL $2.05
- PCVX N/A
- Revenue Next Year
- TOL $7.21
- PCVX N/A
- P/E Ratio
- TOL $9.00
- PCVX N/A
- Revenue Growth
- TOL 8.52
- PCVX N/A
- 52 Week Low
- TOL $95.46
- PCVX $58.10
- 52 Week High
- TOL $169.52
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- TOL 53.40
- PCVX 48.31
- Support Level
- TOL $131.81
- PCVX $77.52
- Resistance Level
- TOL $137.51
- PCVX $89.65
- Average True Range (ATR)
- TOL 3.19
- PCVX 3.95
- MACD
- TOL 2.09
- PCVX 0.77
- Stochastic Oscillator
- TOL 84.08
- PCVX 62.04
About TOL Toll Brothers Inc.
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-home buyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US It has its headquarters in Horsham, Pennsylvania.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.